Cadelius 600 mg / 1,000 IU orodispersible tablets
*Company:
Consilient Health LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 09 May 2023
File name
SPC Cadelius 600-1000.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 09 May 2023
File name
PIL Cadelius 600-1000.pdf
Reasons for updating
- New PIL for new product
Updated on 28 January 2022
File name
ie-spc-clean-09.11.2021.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 28 January 2022
File name
P1392 - appr. Jan 2022.pdf
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 14 October 2019
File name
SmPC.pdf
Reasons for updating
- Change to improve clarity and readability
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
There have been no text / content changes made to this version of the SmPC.
The update was a formatting one.
Updated on 14 October 2019
File name
SmPC.pdf
Reasons for updating
- Change to improve clarity and readability
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
No change to the SmPC text/content with this update
Updated on 23 July 2019
File name
SmPC-renewal-correct section numbers- 23.07.2019.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
It was noted that previous version of SmPC has incorrect section numbers on Section 7, 8 & 9 which were corrected in this version.
Updated on 15 July 2019
File name
03673 Pr CADELIUS 600mg 150x280 (1)-PIL.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 15 July 2019
File name
SmPC-cadelius latest.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 02 October 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 29 September 2017
File name
PIL_17317_481.pdf
Reasons for updating
- New PIL for new product
Consilient Health Ltd
Address:
Block 2A Richview Office Park, Clonskeagh, Dublin 14, IrelandMedical Information E-mail:
drugsafety@consilienthealth.comTelephone:
353 1 2057760Medical Information Facsimile:
+44 (0) 203 751 1889Medical Information Direct Line:
+44 (0) 203 751 1888